Angelo Armandi

59PUBLICATIONS
162CO-AUTHORS
Predictive and prognostic markersMetabolic medicineEnvironmental epidemiologyMedical biochemistry - lipidsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Oct 13, 2026
Beyond BCLC and AFP: A Circulating IL-6/IL-8 Inflammatory Signature Refines Survival Prediction in Hepatocellular Carcinoma.

|Jul 17, 2026
Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

|Jul 15, 2026
Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease.

|Mar 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.

Yuping Chen, Bingtian Dong, Xinrui Jin

|Jul 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort.

Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi

|Jun 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.

Jimmy Che-To Lai, Boyu Yang, Hye Won Lee

Pageof 10

Frequent Collaborators

34 joint publications

Gian Paolo Caviglia

28 joint publications

Chiara Rosso

28 joint publications

Davide Giuseppe Ribaldone

23 joint publications

Elisabetta Bugianesi